Kurt Possinger
Mitte, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in Germany.
Journal: Breast care (Basel, Switzerland)
Published: January 15, 2020
Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
Journal: Anticancer research
Published: March 11, 2018
Cisplatin Plus Ifosfamide with/without Etoposide as Salvage Treatment in Heavily-pre-treated Patients with Metastatic Breast Cancer.
Journal: Anticancer research
Published: August 09, 2015
Pretreatment of BMSCs with TZD solution decreases the proliferation rate of MCF‑7 cells by reducing FGF4 protein expression.
Journal: Molecular medicine reports
Published: May 19, 2015
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).
Journal: Breast care (Basel, Switzerland)
Published: January 14, 2014
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 26, 2013
Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998.
Journal: Onkologie
Published: December 21, 2013
Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 21, 2013
Metastatic breast cancer: are we treating the same patients as in the past?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 27, 2013
Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: June 01, 2013
Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer.
Journal: Breast cancer research and treatment
Published: May 06, 2013
Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: August 29, 2012
Last Updated: 09/26/2026